Rheumatology
1041 – 1050 of 1579
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Measures and time points relevant for post-surgical follow-up in patients with inflammatory arthritis: a pilot study
(
- Contribution to journal › Article
-
Mark
Asporin competes with decorin for collagen binding, binds calcium and promotes osteoblast collagen mineralization
(
- Contribution to journal › Article
-
Mark
Monitoring Arthritis - Biochemical, Metodological and Clinical Aspects
(
- Thesis › Doctoral thesis (compilation)
-
Mark
C1q inhibits immune complex induced IFN-alpha production in plasmacytoid dendritic cells-A novel link between C1q deficiency and SLE pathogenesis
2009) 12th European Meeting on Complement in Human Disease In Molecular Immunology 46(14). p.2857-2857(
- Contribution to journal › Published meeting abstract
-
Mark
A large multicentre analysis of CTGF - 2945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype
(
- Contribution to journal › Article
-
Mark
Natural course of knee osteoarthritis in middle-aged subjects with knee pain: 12-year follow-up using clinical and radiographic criteria
(
- Contribution to journal › Article
-
Mark
Disease activity level, remission and response in established rheumatoid arthritis: Performance of various criteria sets in an observational cohort, treated with anti-TNF agents
(
- Contribution to journal › Article
-
Mark
The cartilage-specific collagen IX and its role in modulation of the complement activity
2009) 12th European Meeting on Complement in Human Disease In Molecular Immunology 46(14). p.2854-2854(
- Contribution to journal › Published meeting abstract
-
Mark
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas:relative risks and time-trends in the Swedish Biologics Register
(
- Contribution to journal › Article
-
Mark
Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden
(
- Contribution to journal › Article